Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$148M |
| 2 |
Mondelez International
MDLZ
|
+$144M |
| 3 |
Johnson & Johnson
JNJ
|
+$64.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$53.4M |
| 5 |
Microsoft
MSFT
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$225M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$151M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$91.6M |
| 4 |
Walmart Inc
WMT
|
+$87.7M |
| 5 |
JPMorgan Chase
JPM
|
+$79.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 29.71% |
| 2 | Healthcare | 20.65% |
| 3 | Consumer Discretionary | 10.85% |
| 4 | Financials | 7.63% |
| 5 | Technology | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
TTEC Holdings
TTEC
$124M
| $304K | ﹤0.01% |
6,861
-1,833
| -21% | -$109K |
|
827
Twilio
TWLO
$36.6B
| $304K | ﹤0.01% |
4,397
-2,905
| -40% | -$232K |
|
|
PDM
828
Piedmont Realty Trust
PDM
$1.19B
| $290K | ﹤0.01% |
27,507
-3,611
| -12% | -$45.3K |
|
829
Robert Half
RHI
$4.37B
| $289K | ﹤0.01% |
3,772
-80,097
| -96% | -$6.26M |
|
830
OptimizeRx
OPRX
$133M
| $284K | ﹤0.01% |
19,197
-26,932
| -58% | -$532K |
|
|
DOCU
831
DocuSign
DOCU
$11.5B
| $278K | ﹤0.01% |
5,191
-12,084
| -70% | -$758K |
|
832
Sun Communities
SUI
$14.7B
| $276K | ﹤0.01% |
2,043
-38,615
| -95% | -$6.11M |
|
833
Capitol Federal Financial
CFFN
$1.1B
| $272K | ﹤0.01% |
32,773
+22,220
| +211% | +$207K |
|
834
Dolby
DLB
$5.79B
| $267K | ﹤0.01% |
4,095
-2,823
| -41% | -$210K |
|
835
Alnylam Pharmaceuticals
ALNY
$29.3B
| $257K | ﹤0.01% |
1,283
-229
| -15% | -$43.7K |
|
836
Acuity Brands
AYI
$10.8B
| $255K | ﹤0.01% |
1,622
-42,040
| -96% | -$7.11M |
|
837
Harley-Davidson
HOG
$2.71B
| $252K | ﹤0.01% |
7,231
-300,970
| -98% | -$11.3M |
|
838
Semtech
SMTC
$13B
| $241K | ﹤0.01% |
+8,204
| New | +$384K |
|
839
Universal Corp
UVV
$1.27B
| $235K | ﹤0.01% |
5,102
-948
| -16% | -$49.6K |
|
|
SGEN
840
DELISTED
Seagen Inc. Common Stock
SGEN
| $235K | ﹤0.01% |
1,717
-10,742
| -86% | -$1.75M |
|
841
Oracle
ORCL
$423B
| $228K | ﹤0.01% |
3,735
-176,006
| -98% | -$12.9M |
|
842
Amphenol
APH
$209B
| $224K | ﹤0.01% |
6,686
-89,494
| -93% | -$3.25M |
|
843
KB Home
KBH
$3.59B
| $224K | ﹤0.01% |
8,623
-53,082
| -86% | -$1.6M |
|
844
Delek US
DK
$3.58B
| $220K | ﹤0.01% |
+8,105
| New | +$214K |
|
|
HUYA
845
Huya Inc
HUYA
$558M
| $220K | ﹤0.01% |
98,931
-3,487
| -3% | -$11.3K |
|
846
ITT
ITT
$19.1B
| $220K | ﹤0.01% |
3,362
-2,375
| -41% | -$173K |
|
847
Tenet Healthcare
THC
$21.1B
| $220K | ﹤0.01% |
+4,272
| New | +$254K |
|
848
Newmont
NEM
$119B
| $216K | ﹤0.01% |
5,140
-296,623
| -98% | -$13.9M |
|
849
U-Haul Holding Co
UHAL
$14.6B
| $216K | ﹤0.01% |
4,250
-51,020
| -92% | -$2.67M |
|
850
Trex
TREX
$5.01B
| $215K | ﹤0.01% |
4,890
-40,348
| -89% | -$2.16M |
|
Similar funds
Ray Dalio's Q3 2022 Portfolio in Review
As of Q3 2022, Ray Dalio held 1,045 positions worth $19.8B, down 16% from $23.6B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio withdrew a net $2.53B in Q3 2022, closing 179 positions and reducing 498 holdings. Its most notable exit was Medtronic, an estimated $225M position sold in full.
By sector, the portfolio is most concentrated in Consumer Staples at 30% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ray Dalio opened a new position in Accenture worth $29.3M.
- Ray Dalio's largest Q3 2022 buy was Accenture: 113,811 shares worth $29.3M.
- Ray Dalio added most to Visa in Q3 2022, an estimated $148M increase.
- Ray Dalio's biggest Q3 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $151M.
- Ray Dalio fully exited Medtronic in Q3 2022, selling an estimated $225M.
- Ray Dalio's ten largest holdings make up 32% of its $19.8B portfolio in Q3 2022.
- Ray Dalio opened 60 new positions and closed 179 in Q3 2022.
- Ray Dalio's portfolio value fell 16% quarter-over-quarter to $19.8B.
Based on Bridgewater Associates's 13F filing for Q3 2022, filed 10 Nov 2022.